Related Experiment Video
Updated: Nov 17, 2025

Author Spotlight: Unveiling the Polyfunctionality and Heterogeneity in Immune Responses
Published on: March 8, 2024
[Pediatric COVID-19 - Pathophysiology, immune responses, genetic predispositions, hyperinflammatory syndrome]
Géraldine Blanchard-Rohner1, Jana Pachlopnik Schmid2, Fabio Candotti3
1Unité d'immunologie-vaccinologie pédiatrique, Service de pédiatrie générale, Département de la femme, de l'enfant et de l'adolescent, HUG, 1211 Genève 14.
Insights
Children initially seemed spared from SARS-CoV-2, but multisystem inflammatory syndrome in children (MIS-C) emerged. This syndrome suggests an immune overreaction, with its mechanisms and risk factors still under investigation.
Area of Science:
- Pediatric immunology
- Infectious diseases
- Viral pathogenesis
Background:
- The SARS-CoV-2 pandemic initially appeared to spare children from severe illness.
- However, a novel inflammatory condition, multisystem inflammatory syndrome in children (MIS-C), emerged in spring 2020.
- The characteristics of MIS-C suggest an immunologic response rather than direct viral damage.
Purpose of the Study:
- To review current knowledge on the immune response to SARS-CoV-2 in pediatric populations.
- To summarize the understanding of multisystem inflammatory syndrome in children (MIS-C).
- To explore potential immunologic mechanisms and risk factors for MIS-C.
Main Methods:
- Literature review of studies on SARS-CoV-2 infection in children.
- Analysis of clinical data and immunological findings related to MIS-C.
- Synthesis of existing research on pediatric inflammatory responses to viral infections.
Main Results:
- Children mount distinct immune responses to SARS-CoV-2 compared to adults.
- MIS-C presents with significant inflammation affecting multiple organ systems.
- The interval between SARS-CoV-2 infection and MIS-C onset points to a post-infectious immune dysregulation.
Conclusions:
- MIS-C is a serious post-infectious complication in children, likely driven by immune system dysregulation.
- Further research is needed to fully elucidate the pathophysiology and identify risk factors for MIS-C.
- Understanding the pediatric immune response to SARS-CoV-2 is crucial for managing MIS-C.
Abstract:
Children appeared to be initially spared by the SARS-CoV-2 pandemic, however, in spring 2020, a new clinical entity was described related to the SARS-CoV-2 infection and named multisystem inflammatory syndrome in children (MIS-C) or pediatric inflammatory multisystem syndrome (PIMS). The gravity of this inflammatory syndrome, the time interval between infection and MIS-C, the response to the various immunomodulatory treatments are all suggestive of an immunologic reaction rather than a virus-mediatred phenomenon. The pathophysiological mechanisms and possible risk factors for MIS-C have not been elucidated. In this article, we summarize what is known to date about the immune response to SARS-CoV-2 in children and about the immune response to SARS-CoV-2 in children and about the MIS-C.
More Related Videos
Related Concept Videos
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Pneumonia II: Pathophysiology
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:

